[HTML][HTML] Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
X Ma, H Zhu, H Guo, A Han, H Wang, W Jing, Y Zhang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Controversial value of prophylactic cranial irradiation (PCI) in NSCLC in terms of survival
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
X Ma, H Zhu, H Guo, A Han, H Wang, W Jing… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Controversial value of prophylactic cranial irradiation (PCI) in NSCLC in terms of survival
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
[PDF][PDF] Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
X Ma, H Zhu, H Guo, A Han, H Wang, W Jing, Y Zhang… - pdfs.semanticscholar.org
Controversial value of prophylactic cranial irradiation (PCI) in NSCLC in terms of survival
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma.
X Ma, H Zhu, H Guo, A Han, H Wang, W Jing, Y Zhang… - Oncotarget, 2016 - europepmc.org
Controversial value of prophylactic cranial irradiation (PCI) in NSCLC in terms of survival
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
benefit prompted us to explore the possible risk factors for brain metastasis (BM) during the …
[HTML][HTML] Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
X Ma, H Zhu, H Guo, A Han, H Wang, W Jing, Y Zhang… - Oncotarget, 2016 - oncotarget.com
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with
EGFR-mutated advanced lung adenocarcinoma | Oncotarget Online ISSN: 1949-2553 Search …
EGFR-mutated advanced lung adenocarcinoma | Oncotarget Online ISSN: 1949-2553 Search …
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
X Ma, H Zhu, H Guo, A Han, H Wang, W Jing, Y Zhang… - Oncotarget, 2016 - oncotarget.com
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with
EGFR-mutated advanced lung adenocarcinoma | Oncotarget Online ISSN: 1949-2553 Search …
EGFR-mutated advanced lung adenocarcinoma | Oncotarget Online ISSN: 1949-2553 Search …